This CME activity, “Evaluation and Management of IBS and CIC”, was originally presented live in San Antonio, TX on November 12, 2021 at the 2021 Best Practices in Primary Care CME conference. During this activity, faculty will discuss the role of Rome-IV criteria and other tests used for diagnosing IBS, as well as differentiating the different subtypes of IBS. The faculty reviews the benefits and limitations of IBS and CIC prescription medications and how to individualize treatment based on current evidence-based guidelines.
Irritable Bowel Syndrome (IBS) affects 15% of the population. They are a challenging group whose care can often be frustrating. This activity will explain why the diagnosis of IBS in 2020 is no longer a “diagnosis of exclusion”.
Between Thanksgiving and the winter holidays, clinic has been busier than ever with patients making last-minute appointments for sick visits. Some of your patients have been cycling in and out of clinic for weeks, toggling between upper respiratory symptoms and gastrointestinal illnesses. For example, when you last saw Mark three weeks ago, he had been sick with a fever, runny nose, and cough.